Literature DB >> 19304711

Automated algorithm for quantifying the extent of cystic change on volumetric chest CT: initial results in Lymphangioleiomyomatosis.

Vincent J Schmithorst1, Talissa A Altes, Lisa R Young, David N Franz, John J Bissler, Francis X McCormack, Bernard J Dardzinski, Alan S Brody.   

Abstract

OBJECTIVE: The purpose of our study was to develop a new method for quantifying the severity of cystic lung disease using chest CT and to evaluate this method in patients with lymphangioleiomyomatosis (LAM). SUBJECTS AND METHODS: Eighteen patients with LAM (all women; mean age, 43.6 years) underwent chest CT and pulmonary function testing including diffusing capacity for carbon monoxide (DLCO). All patients were at their clinical baseline on the day of imaging. Standard quantitative CT metrics including the percentage of the lung volume < -910 HU and the 15th percentile of Hounsfield units were computed from the histogram of lung voxels. A new histogram analysis method was developed to compute the cyst volume and the volume of the remaining lung by segmenting the entire lung attenuation histogram into two underlying distributions, one from the cysts and the other from the remaining lung tissue.
RESULTS: The mean +/- SD for quantitative lung metrics was 21% +/- 16% for percentage < -910 HU, -915 +/- 47 HU for 15th percentile of Hounsfield units, and 19% +/- 13% for cyst volume. The correlation between pulmonary function tests and CT metrics was strongest for the percentage of cyst volume for all pulmonary function testing indexes, with correlations between forced expiratory volume in 1 second (FEV(1)) percentage predicted and the CT metrics of r = -0.52, r = 0.50, and r = -0.86 for the percentage of lung < -910 HU, the 15th percentile of Hounsfield units, and the percentage of cyst volume, respectively.
CONCLUSION: A new method for quantifying cyst volume as a percentage of total lung volume using chest CT correlates with pulmonary function parameters in patients with LAM and may have utility in the assessment of disease severity and progression of cystic lung diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19304711     DOI: 10.2214/AJR.07.3334

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  14 in total

Review 1.  Lung densitometry: why, how and when.

Authors:  Mario Mascalchi; Gianna Camiciottoli; Stefano Diciotti
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

2.  The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.

Authors:  Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Joel Moss
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

3.  Clinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis.

Authors:  Brent Kinder; Francis X McCormack
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

4.  Automated quantification of high-resolution CT scan findings in individuals at risk for pulmonary fibrosis.

Authors:  Ivan O Rosas; Jianhua Yao; Nilo A Avila; Catherine K Chow; William A Gahl; Bernadette R Gochuico
Journal:  Chest       Date:  2011-05-26       Impact factor: 9.410

5.  Clinical CT underestimation of the percentage volume occupied by cysts in patients with lymphangioleiomyomatosis.

Authors:  Thomas C Larsen; Amir M Hasani; Shirley F Rollison; Tania R Machado; Amanda M Jones; Patricia Julien-Williams; Marcus Y Chen; Joel Moss; Han Wen
Journal:  Clin Imaging       Date:  2019-11-27       Impact factor: 1.605

6.  Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.

Authors:  Connie G Glasgow; Wendy K Steagall; Angelo Taveira-Dasilva; Gustavo Pacheco-Rodriguez; Xiong Cai; Souheil El-Chemaly; Marsha Moses; Thomas Darling; Joel Moss
Journal:  Respir Med       Date:  2010-07       Impact factor: 3.415

7.  Quantitative Analysis of Cystic Lung Diseases by Use of Paired Inspiratory and Expiratory CT: Estimation of the Extent of Cyst-Airway Communication and Evaluation of Diagnostic Utility.

Authors:  Kazuhiro Suzuki; Kuniaki Seyama; Hiroki Ebana; Toshio Kumasaka; Ryohei Kuwatsuru
Journal:  Radiol Cardiothorac Imaging       Date:  2020-04-30

8.  Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).

Authors:  Bruno Guedes Baldi; Mariana Sponholz Araujo; Carolina Salim Gonçalves Freitas; Gustavo Borges da Silva Teles; Ronaldo Adib Kairalla; Olívia Meira Dias; Daniel Antunes Silva Pereira; Suzana Pinheiro Pimenta; Carlos Roberto Ribeiro Carvalho
Journal:  Lung       Date:  2014-09-09       Impact factor: 2.584

9.  EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.

Authors:  Angelo M Taveira-DaSilva; Joel Moss
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-07       Impact factor: 0.694

10.  Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis.

Authors:  Brianna P Matthew; Amir M Hasani; Yun-Ching Chen; Mehdi Pirooznia; Mario Stylianou; Shirley F Rollison; Tania R Machado; Nora M Quade; Amanda M Jones; Patricia Julien-Williams; Angelo Taveira-DaSilva; Marcus Y Chen; Joel Moss; Han Wen
Journal:  Chest       Date:  2021-02-05       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.